![PDF] Albuterol aerosol delivered via metered-dose inhaler to intubated pediatric models of 3 ages, with 4 spacer designs. | Semantic Scholar PDF] Albuterol aerosol delivered via metered-dose inhaler to intubated pediatric models of 3 ages, with 4 spacer designs. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/a4ba725b7e3c0b3f14d07b7d5acf5a487a0af235/2-Table1-1.png)
PDF] Albuterol aerosol delivered via metered-dose inhaler to intubated pediatric models of 3 ages, with 4 spacer designs. | Semantic Scholar
![PDF] Nebulizers vs metered-dose inhalers with spacers for bronchodilator therapy to treat wheezing in children aged 2 to 24 months in a pediatric emergency department. | Semantic Scholar PDF] Nebulizers vs metered-dose inhalers with spacers for bronchodilator therapy to treat wheezing in children aged 2 to 24 months in a pediatric emergency department. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/1fef1372be98e8bfb5ba78f8f8f8f6b8feef9b7a/3-Table2-1.png)
PDF] Nebulizers vs metered-dose inhalers with spacers for bronchodilator therapy to treat wheezing in children aged 2 to 24 months in a pediatric emergency department. | Semantic Scholar
![Pharmaceutics | Free Full-Text | Quantifying Delivered Dose with Jet and Mesh Nebulizers during Spontaneous Breathing, Noninvasive Ventilation, and Mechanical Ventilation in a Simulated Pediatric Lung Model with Exhaled Humidity Pharmaceutics | Free Full-Text | Quantifying Delivered Dose with Jet and Mesh Nebulizers during Spontaneous Breathing, Noninvasive Ventilation, and Mechanical Ventilation in a Simulated Pediatric Lung Model with Exhaled Humidity](https://www.mdpi.com/pharmaceutics/pharmaceutics-13-01179/article_deploy/html/images/pharmaceutics-13-01179-g001-550.jpg)
Pharmaceutics | Free Full-Text | Quantifying Delivered Dose with Jet and Mesh Nebulizers during Spontaneous Breathing, Noninvasive Ventilation, and Mechanical Ventilation in a Simulated Pediatric Lung Model with Exhaled Humidity
![From the infant to the geriatric patient—Strategies for inhalation therapy in asthma and chronic obstructive pulmonary disease - Hagmeyer - 2023 - The Clinical Respiratory Journal - Wiley Online Library From the infant to the geriatric patient—Strategies for inhalation therapy in asthma and chronic obstructive pulmonary disease - Hagmeyer - 2023 - The Clinical Respiratory Journal - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/76f7da94-0172-4a2d-82a4-5536b673cdc4/crj13610-toc-0001-m.jpg?trick=1703020526933)
From the infant to the geriatric patient—Strategies for inhalation therapy in asthma and chronic obstructive pulmonary disease - Hagmeyer - 2023 - The Clinical Respiratory Journal - Wiley Online Library
![Albuterol via metered‐dose inhaler in children: Lower doses are effective, and higher doses are safe - Muchão - 2016 - Pediatric Pulmonology - Wiley Online Library Albuterol via metered‐dose inhaler in children: Lower doses are effective, and higher doses are safe - Muchão - 2016 - Pediatric Pulmonology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/3da3e003-07d0-47ee-8c77-8739fb21eaad/ppul23469-fig-0001-m.jpg)
Albuterol via metered‐dose inhaler in children: Lower doses are effective, and higher doses are safe - Muchão - 2016 - Pediatric Pulmonology - Wiley Online Library
![PDF] Albuterol Delivery by 4 Different Nebulizers Placed in 4 Different Positions in a Pediatric Ventilator In Vitro Model | Semantic Scholar PDF] Albuterol Delivery by 4 Different Nebulizers Placed in 4 Different Positions in a Pediatric Ventilator In Vitro Model | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/bf3b450148815a70f1206acd76d8dfa15e8b6ca4/7-Table3-1.png)
PDF] Albuterol Delivery by 4 Different Nebulizers Placed in 4 Different Positions in a Pediatric Ventilator In Vitro Model | Semantic Scholar
![Albuterol Sulfate Inhalation Solution0.042% (1.25 mg*/3 mL) and 0.021% (0.63 mg*/3 mL)(*Potency expressed as albuterol, equivalent to 1.5 mgand 0.75 mg albuterol sulfate) Revised: January 2017 Rx only Albuterol Sulfate Inhalation Solution0.042% (1.25 mg*/3 mL) and 0.021% (0.63 mg*/3 mL)(*Potency expressed as albuterol, equivalent to 1.5 mgand 0.75 mg albuterol sulfate) Revised: January 2017 Rx only](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=image-8.jpg&id=427002)